Who Owns Exact Sciences Company?
Exact Sciences is a public company on Nasdaq under EXAS, so it is owned by shareholders, not a parent group. Its ownership is shaped by institutions, insiders, and voting rights. For a quick strategy view, see the Exact Sciences PESTEL Analysis.
Exact Sciences was founded in 1995 and went public in 2001, which spread ownership across the market. The key question is who holds the most voting power now.
Who Founded Exact Sciences?
Exact Sciences ownership started with founders and early backers who financed a small diagnostics idea before it became a public company. Today, Exact Sciences shareholders are mainly public-market investors, not a controlling family or private owner.
Early founder control
Exact Sciences began as a startup in 1995, and early ownership was concentrated among founders, employees, and venture backers. That structure changed as the business raised capital and expanded.
Private capital phase
Before the listing, ownership was mostly private and limited to insiders and early investors. That gave the founders more control, but it also tied growth to outside funding.
Public listing shift
Once Exact Sciences became publicly traded, the ownership base widened fast. The Exact Sciences stock now changes hands across institutions, funds, and retail holders.
Who owns Exact Sciences today
Exact Sciences is owned by public shareholders because it is an publicly traded company. In practice, Exact Sciences institutional investors and other market holders make up most of the economic ownership.
Insiders versus institutions
Exact Sciences insider ownership is much smaller than institutional ownership. That means executives can influence strategy, but they do not control the company alone.
Ownership transparency
The Exact Sciences public company ownership structure depends on SEC filings and board oversight. The Brief History of Exact Sciences gives the wider path from startup to listed company.
Exact Sciences shareholders today are mainly institutions, mutual funds, ETFs, and other public owners, so there is no single dominant controller. Large holders often include firms such as Vanguard, BlackRock, and State Street in 13F filings, but Exact Sciences ownership breakdown by institution changes every quarter.
Exact Sciences ownership at a glance
Exact Sciences is a public company, so ownership is spread across many stockholders and owners. That structure supports liquidity, but it also means investors rely on SEC reporting, management execution, and board discipline.
- No controlling family or private sponsor
- Institutions hold most visible shares
- Insiders hold a smaller stake
- Ownership changes with 13F filings
- Market cap moves with the stock price
Exact Sciences SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Exact Sciences’s Ownership Changed Over Time?
Exact Sciences was founded in 1995, went public in 2001, and changed again in 2019 when it bought Genomic Health for about 2.8 billion in stock. Those steps shifted Exact Sciences ownership from early-stage control to a public company model shaped by Exact Sciences shareholders, Exact Sciences institutional investors, and market scrutiny.
| Key ownership event | Effect on control | Investor meaning |
|---|---|---|
| 1995 founding | Founder-led start | Early control sat with founders and early backers |
| 2001 IPO | Public company ownership structure | Exact Sciences stock became broadly held and traded |
| 2019 Genomic Health deal | More scale, more dilution | Added Oncotype DX and widened the testing platform |
| Current public market base | Board and shareholders govern | Ownership is driven by institutions, not a private sponsor |
Who owns Exact Sciences today is best read through its public filings: it is publicly traded, so Exact Sciences stockholders and owners are a mix of institutions, insiders, and retail holders. In practice, Exact Sciences insider ownership is usually much smaller than Exact Sciences institutional ownership percentage, which is why the market focuses on filings, earnings, and guidance rather than founder control. For a business model view, see Revenue Streams & Business Model of Exact Sciences.
Ownership, trust, and market reading
Exact Sciences ownership shapes how doctors, payors, and investors judge the company. Public ownership can support trust, but it also raises pressure for quarterly growth and margin control.
- Exact Sciences public company ownership structure limits founder control
- Exact Sciences shareholders expect clear reimbursement wins
- Exact Sciences board of directors and ownership drive oversight
- Exact Sciences major shareholders list is institution-led
- Exact Sciences current market capitalization moves with execution
Exact Sciences PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Exact Sciences’s Board?
Exact Sciences is overseen by a standard public-company board, executive management, and standing committees. In Exact Sciences ownership, voting power is tied to shares, so no single holder gets built-in control.
| Governance point | What it means | Why it matters |
|---|---|---|
| Board oversight | Directors supervise strategy and management | Sets the tone on risk and capital use |
| One-share, one-vote | Voting power tracks share ownership | Exact Sciences shareholders can matter in proxy votes |
| Independent committees | Audit and compensation review key issues | Supports credibility with Exact Sciences institutional investors |
Who owns Exact Sciences is best read through its public-company ownership structure, not a founder lockup or dual-class control. Exact Sciences stockholders and owners mainly influence outcomes through director elections, say-on-pay votes, and support from large institutions; that is why Exact Sciences institutional ownership percentage and Exact Sciences insider ownership both matter in any Exact Sciences company overview. For a related view on strategy and market position, see Target Market of Exact Sciences.
Who Holds Real Influence Over the Brand
The real influence sits with the board, the CEO, and the largest shareholders. Exact Sciences public company ownership structure gives investors real voting rights, so proxy seasons can move governance and strategy.
- Board elections shape strategic oversight.
- Independent directors lift governance credibility.
- Institutions can sway key votes.
- CEO changes can reset market trust.
Exact Sciences Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Exact Sciences’s Ownership Landscape?
Exact Sciences ownership has stayed stable in structure: it is still a publicly traded company with no controlling family or private owner. Recent ownership trends point to a wide institutional base, while credibility keeps hinging on execution, not control, as investors watch Cologuard growth, Genomic Health integration, and margin progress.
| Ownership area | Recent trend | Why it matters |
|---|---|---|
| Public company structure | Exact Sciences is publicly traded and widely held. | Supports transparency and market discipline. |
| Institutional ownership | Large funds remain the main holders of Exact Sciences stock. | Signals deep analyst and portfolio-manager oversight. |
| Insider ownership | Management and directors do not control the company. | Reduces founder-style control risk. |
In the Exact Sciences company overview, ownership matters most because diagnostics buyers want evidence, not insider influence. The Mission, Vision & Core Values of Exact Sciences story fits a public-company model where disclosure, regulation, and outside ownership shape trust.
Public ownership model
Exact Sciences follows a standard public company ownership structure. That keeps reporting frequent and visible for Exact Sciences shareholders.
Institutional base
Exact Sciences institutional investors shape most of the float. That usually means more scrutiny on growth, cash flow, and execution.
Credibility link
Who owns Exact Sciences is less important than how it performs. In diagnostics, brand credibility rises when results meet payer and physician expectations.
Control and governance
Who controls Exact Sciences company is the board and voting shareholders, not a founder bloc. That lowers concentration risk and supports governance checks.
Exact Sciences shareholders are still best understood through its listed equity base, not through private control. Exact Sciences stock ownership remains tied to public market disclosure, so the main question for investors is not who founded Exact Sciences company, but whether operating results keep matching the ownership narrative.
Exact Sciences Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What is Brief History of Exact Sciences Company?
- What is Competitive Landscape of Exact Sciences Company?
- What is Growth Strategy and Future Prospects of Exact Sciences Company?
- How Does Exact Sciences Company Work?
- What is Sales and Marketing Strategy of Exact Sciences Company?
- What are Mission Vision & Core Values of Exact Sciences Company?
- What is Customer Demographics and Target Market of Exact Sciences Company?
Frequently Asked Questions
Exact Sciences is owned by public shareholders because it trades on Nasdaq under EXAS. There is no parent company or controlling family. The business was founded in 1995 and went public in 2001, so ownership has been dispersed for more than two decades. Institutions and insiders matter most for voting and sentiment.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.